Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 1
2012 2
2013 1
2014 2
2016 2
2017 4
2018 6
2019 12
2020 3
2021 8
2022 2
2023 9
2024 4
2025 9
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis.
Maurer MS, Kale P, Fontana M, Berk JL, Grogan M, Gustafsson F, Hung RR, Gottlieb RL, Damy T, González-Duarte A, Sarswat N, Sekijima Y, Tahara N, Taylor MS, Kubanek M, Donal E, Palecek T, Tsujita K, Tang WHW, Yu WC, Obici L, Simões M, Fernandes F, Poulsen SH, Diemberger I, Perfetto F, Solomon SD, Di Carli M, Badri P, White MT, Chen J, Yureneva E, Sweetser MT, Jay PY, Garg PP, Vest J, Gillmore JD; APOLLO-B Trial Investigators. Maurer MS, et al. N Engl J Med. 2023 Oct 26;389(17):1553-1565. doi: 10.1056/NEJMoa2300757. N Engl J Med. 2023. PMID: 37888916 Free PMC article. Clinical Trial.
At month 12, the decline in the 6-minute walk distance was lower in the patisiran group than in the placebo group (Hodges-Lehmann estimate of median difference, 14.69 m; 95% confidence interval [CI], 0.69 to 28.69; P = 0.02); the KCCQ-OS score increased in the patisiran gr …
At month 12, the decline in the 6-minute walk distance was lower in the patisiran group than in the placebo group (Hodges-Lehmann estimate o …
Patterning and folding of intestinal villi by active mesenchymal dewetting.
Huycke TR, Häkkinen TJ, Miyazaki H, Srivastava V, Barruet E, McGinnis CS, Kalantari A, Cornwall-Scoones J, Vaka D, Zhu Q, Jo H, Oria R, Weaver VM, DeGrado WF, Thomson M, Garikipati K, Boffelli D, Klein OD, Gartner ZJ. Huycke TR, et al. Cell. 2024 Jun 6;187(12):3072-3089.e20. doi: 10.1016/j.cell.2024.04.039. Epub 2024 May 22. Cell. 2024. PMID: 38781967 Free PMC article.
Thrombocytopenia in patients with inborn errors of immunity.
Fekrvand S, Mohtashami M, Sanadgol N, Salehi H, Fard NNG, Afkham EK, Chavoshzadeh Z, Parvaneh N, Mahdaviani SA, Sharafian S, Barzamini S, Ahanchian H, Kalantari A, Shafiei A, Tavakol M, Abolnezhadian F, Rad MK, Hassanpour G, Cheraghi T, Farid AS, Delavari S, Abolhassani H, Rezaei N, Yazdani R. Fekrvand S, et al. BMC Immunol. 2025 Sep 29;26(1):74. doi: 10.1186/s12865-025-00761-0. BMC Immunol. 2025. PMID: 41023781 Free PMC article.
METHODS: In the present study, we assessed frequency of thrombocytopenia in the most common IEI including combined immunodeficiency (CID), common variable immunodeficiency (CVID), selective immunoglobulin A deficiency (SIgAD), agammaglobulinemia (AGA), hyper immunoglobulin M …
METHODS: In the present study, we assessed frequency of thrombocytopenia in the most common IEI including combined immunodeficiency (CID), c …
Management of high-grade neuroendocrine neoplasms: impact of functional imaging.
Islam O, Sarti K, Verbruggen L, Vandersmissen V, Bulcke KV, Annys L, Verslype C, Van Laethem JL, Kalantari HR, Janssens J, Hendlisz A, Cuyle PJ, Demolin G, Decaestecker J, Geboes K, Coche JC, Van Ongeval J, Lybaert W, Peeters M, Borbath I, Vandamme T. Islam O, et al. Endocr Relat Cancer. 2025 Feb 19;32(4):e240231. doi: 10.1530/ERC-24-0231. Print 2025 Apr 1. Endocr Relat Cancer. 2025. PMID: 39888333
Median overall survival (mOS) was higher in NET G3 (41.3 months (m)) compared to NEC (13.2m). Of those who underwent functional imaging, fluorodeoxyglucose-positron emission tomography (18F-FDG-PET) imaging was positive in 90.6 and 95.6% of the NET G3 and NEC patients, res …
Median overall survival (mOS) was higher in NET G3 (41.3 months (m)) compared to NEC (13.2m). Of those who underwent functional imagi …
Clinical Manifestations, Immunological Characteristics and Genetic Analysis of Patients with Hyper-Immunoglobulin M Syndrome in Iran.
Tafakori Delbari M, Cheraghi T, Yazdani R, Fekrvand S, Delavari S, Azizi G, Chavoshzadeh Z, Mahdaviani SA, Ahanchian H, Khoshkhui M, Behmanesh F, Aleyasin S, Esmaeilzadeh H, Jabbari-Azad F, Fallahpour M, Zamani M, Madani SP, Moazzami B, Habibi S, Rezaei A, Lotfalikhani A, Movahed M, Shariat M, Kalantari A, Babaei D, Darabi M, Parvaneh N, Rezaei N, Abolhassani H, Aghamohammadi A. Tafakori Delbari M, et al. Int Arch Allergy Immunol. 2019;180(1):52-63. doi: 10.1159/000500197. Epub 2019 May 22. Int Arch Allergy Immunol. 2019. PMID: 31117086
BACKGROUND: Hyper-immunoglobulin M (HIGM) syndrome is a rare heterogeneous group of primary immunodeficiency disorders characterized by low or absent serum levels of IgG and IgA along with normal or elevated serum levels of IgM. ...
BACKGROUND: Hyper-immunoglobulin M (HIGM) syndrome is a rare heterogeneous group of primary immunodeficiency disorders characterized …
Prognostic Value of Baseline 18F-FDG PET/CT to Predict Brain Metastasis Development in Melanoma Patients.
Kalantari F, Mirshahvalad SA, Hoellwerth M, Schweighofer-Zwink G, Huber-Schönauer U, Hitzl W, Rendl G, Koelblinger P, Pirich C, Beheshti M. Kalantari F, et al. Cancers (Basel). 2023 Dec 26;16(1):127. doi: 10.3390/cancers16010127. Cancers (Basel). 2023. PMID: 38201554 Free PMC article.
The median follow-up was six years. Among clinical variables, the initial M-stage and TNM-stage were significantly correlated with brain metastasis. Regarding (18)F-FDG-PET/CT parameters, regional metastatic lymph node uptake values, as well as prominent SULmax (pSULmax) a …
The median follow-up was six years. Among clinical variables, the initial M-stage and TNM-stage were significantly correlated with br …
Concurrent of blaCTX-M and blaNDM-1 genes in clinical isolates of Escherichia coli from northern Iran.
Shahandeh Z, Kalantari N, Sadighian F, Aram H, Etminan M. Shahandeh Z, et al. Trop Biomed. 2019 Jun 1;36(2):459-467. Trop Biomed. 2019. PMID: 33597407 Free article.
The present study aimed to evaluate the existence of blaCTX-M, blaTEM, blaSHV, blaNDM-1 and blaIMP1 genes among E. coli isolated from patients in Babol, Northern Iran. ...The ESBLs and MBLs positive isolates were analysed for the existence of blaCTX-M, blaTEM, blaSH …
The present study aimed to evaluate the existence of blaCTX-M, blaTEM, blaSHV, blaNDM-1 and blaIMP1 genes among E. coli isolated from …
63 results